San Diego

September 25, 2024:

March 25, 2024:  The Expanding Role of Pharma in our Ecosystem

   Artie Suckow, CEO, DTx

   Clare Ozawa, Partner, Versant Ventures

   Dan Estes, Partner, Frazier Life Sciences

   Kevin Forrest, CEO, Kate Therapeutics

   Moderated by Aliza Apple, COO & Head of Lilly Gateway Labs West Coast, Lilly 

September 27, 2023:  Implications of the Inflation Reduction Act

   Dina Lynch, Head of Market Access, Alzheon

   Kevin Finney, CEO,  Autobahn Therapeutics

   Matt Wetzel, Partner, Life Sciences, Goodwin

   Sarah Honig, VP, Corporate Development & Strategy, Tyra Biosciences

   Moderated by Mark Spring, Managing Director, Danforth Advisors